ABSTRACT BACKROUND: The purpose of the study was to ascertain the incidence of bleeding and ischaemic complications in patients with cardiac disease after total hip arthroplasty (THA) and total knee arthroplasty (TKA). METHODS: In total, 477 patients (289 women, 188 men) with known history of cardiac disease or thromboembolic disease treated with surgery in 2010-2013, were enrolled in the study. Perioperative prevention of thromboembolic disease using low-molecular-weight heparins was applied in all the patients. The data that could have an impact on the development of monitored perioperative complications, were observed. RESULTS: Complications occurred in 55 (11.6 %) patients: bleeding complications in 32, ischaemic in 19, and both in four patients. Complications were found in 13 (12.0 %) patients after THA and in 6 (9.5 %) patients after TKA. Bleeding complications were observed in 17 patients after THA and TKA, ischaemic in one, and both simultaneously in one patient. Bleeding complications occurred insignifi cantly more frequently after THA and TKA (p = 0.094); however, this difference was statistically signifi cant after adjustment for risk factors (p = 0.003). On the contrary, ischaemic complications were signifi cantly more frequent after other skeletal surgeries (p = 0.014). Nevertheless, this difference was not statistically signifi cant after the adjustment (p = 0.880). The comparison of the risk of complications in patients after THA with that in patients after TKA showed no signifi cant difference (p = 0.580). CONCLUSION: The study showed a signifi cantly higher incidence of bleeding complications in patients after THA and TKA compared to other surgeries of the musculoskeletal system in patients with a history of cardiac disease. Bleeding complications cannot be detected in advance (Tab. 1, Ref. 16). Text in PDF www.elis.sk.
Introduction
Bleeding and ischaemic complications belong to the most serious perioperative problems after skeletal surgeries. These complications may have an important impact on the result of surgery and quality of life (1) (2) (3) (4) (5) (6) (7) . The development of such complications is infl uenced by a number of known factors such as age, weight, history of cardiac or vascular diseases, antithrombotic medication in the preoperative period, hypercoagulable state (1, 5, 8, 9) .
Total hip arthroplasty (THA) and total knee arthroplasty (TKA) implantations rank among surgeries that are most burdened by perioperative and postoperative blood losses. The purpose of this study was to fi nd out whether the risk of bleeding and ischaemic complications after THA and TKA in patients with cardiac disease is higher than that after other orthopaedic and traumatological surgeries of the musculoskeletal system.
Material and methods
The study group included 477 patients undergoing surgery due to an orthopaedic disease or injury to the musculoskeletal system. In their history, the patients had any of diseases as follows: ischaemic heart disease, atrial fi brillation, stroke, deep vein thrombosis in lower limbs, pulmonary embolism, or heart valve surgery. Our study was a subanalysis of the PRAGUE 14 Study (registered on www.ClinicalTrials.gov under the identifi er NCT01897220) with the total number of 1 200 enrolled patients followed in 2011-2013, undergoing any neurosurgery, or thoracic, abdominal, urological or orthopaedic surgery (10) .
The following data were registered in the database system eCRF (web medium APEX, Oracle Application Express 10g, data exported via RapidMiner 5.3): data related to cardiovascular his-tory (myocardial infarction, percutaneous coronary intervention, coronary artery bypass graft, atrial fi brillation, valvular disease, prosthetic valve, stroke, deep vein thrombosis, pulmonary embolism) and the history of antithrombotic medication, data related to the surgery and perioperative period (basic haematological and biochemical test results, anticoagulation perioperative prophylaxis, duration of surgery, perioperative complications), intraoperative bleeding complications (requiring prolongation of surgery) and postoperative bleeding complications (requiring surgical revision or transfusion without revision), postoperative ischaemic complications (acute stroke, myocardial infarction, fi rst or recurrent heart failure, pulmonary embolism, deep vein thrombosis, acute limb ischaemia) and the number of deaths.
Basic data (age, sex, height, weight, surgery type, medication) were evaluated using descriptive statistical methods. The hypotheses were tested by the regression analysis method both without and with adjustment for demonstrated risk factors (sex, age, height, weight, smoking, hypertension, chronic heart failure, percutaneous coronary intervention, warfarin versus warfarin discontinuation three or more days before the surgery, ASA score, general vs local anaesthesia, acute vs elective procedure, haemoglobin < 100 g/L, thrombocytes > 300. 10 12 /L, thrombocytes < 150.10 12 /L, creatinine > 100 mmol/L); statistical software Stata 13 was used.
Results
The study group of 477 patients comprised 289 women (61 %) and 188 men (39 %); of whom 272 (57 %) underwent acute surgery, and 205 (43 %) elective surgery. THA was performed in 108 (23 %) patients and TKA in 63 (13 %) patients. An overview of the surgeries per anatomical site is presented in Table 1 .
The age of all patients ranged from 33 to 99 years (mean age 76 years; median age 78 years), while in patients after THA and TKA, the age ranged from 46 to 94 years (mean age 73 years; median age 75 years).
Complications were observed in 55 (11.6 %) patients: bleeding complications in 32 (6.9 %) and ischaemic complications in 19 (4.0 %) patients, while both types of complications were seen at the same time in 4 (0.8 %) patients. Complications were observed in 13 (12.0 %) patients after THA and 6 (9.5 %) patients after TKA. Bleeding complications were experienced by 17 patients after THA and TKA, ischaemic by one patient, and a combination of bleeding and ischaemia was seen in one patient.
No statistical difference was found upon comparison of all complications in patients after THA or TKA and other operated patients (p = 0.911; odds ratio 0.75; CI = 0.5; 1.6); insignifi cant difference persisted also after adjustment for demonstrated risk factors (age, general anaesthesia) (p = 0.260; odds ratio 1.47; CI = 0.75; 2.85).
Bleeding complications were seen insignifi cantly more frequently after THA and TKA (p = 0.094; odds ratio 1.78; CI = 0.91; 3.49); however, after adjustment (signifi cant: general anaesthesia, borderline insignifi cant: sex, hypertension, warfarin administration), this difference was statistically signifi cant (p = 0.003; odds ratio 3.2; CI = 1.49; 7.0).
On the contrary, ischaemic complications occurred significantly more frequently after other skeletal surgeries (p = 0.014; odds ratio 6.22; CI = 1.44; 26.88); however, after adjustment (signifi cant: age; borderline insignifi cant: thrombocytes < 150.10 12 /L, acute surgery), this difference was statistically insignifi cant (p = 0.880; odds ratio 1.14; CI = 0,2; 3,71).
After comparison of the risk of complications in patients after THA with that in patients after TKA we did not observe any signifi cant difference (p = 0.580; odds ratio 1.34; CI = 0.49; 3.71), and after adjustment (signifi cant: age, general anaesthesia; borderline insignifi cant: warfarin administration, smoking, thrombocytes > 300. 10 12 /L) this difference remained insignifi cant (p = 0.481; odds ratio 1.52; CI = 0.47;4.9). The difference between bleeding complications in patients after THA compared to TKA was also insignificant (p = 0.375; odds ratio 2.0; CI = 0.55; 4.81), and after adjustment (signifi cant: age, general anaesthesia, thrombocytes > 300.10 12 /L, borderline insignifi cant: warfarin administration, smoking) this difference remained insignifi cant (p = 0.273; odds ratio 2.0; CI = 0.57; 7.13). Finally, not even the difference in ischaemic complications between patients after THA compared to those after TKA was signifi cant (p = 0.715; odds ratio 0.59; CI = 0.04; 9.67); adjustment was not possible due to the low incidence of ischaemic complications.
Discussion
In our study, which was focused on the risk of bleeding and ischaemic complications in patients after acute and elective surgeries of the musculoskeletal system, we noted a signifi cantly higher risk of bleeding complications after elective procedures, and contrariwise, a signifi cantly higher risk of ischaemic complications after acute procedures (11) . The higher risk of ischaemic complications in patients after acute procedures was closely related to higher age of patients. We wanted to fi nd out whether the increased risk of bleeding complications in elective procedures could be affected by the most commonly scheduled procedures, i.e. THA and THK. Patients after arthroplasty implantation were slightly younger in our group, but we believe that this minor difference could not have had any impact on the risk.
As shown by our study, bleeding complications occurred signifi cantly more frequently in patients after THA and TKA. We believe this to be especially due to the fact that considerable resection of connective tissue and signifi cant exposure of spongy bone occur after both procedures, meaning that perioperative and subsequent postoperative blood losses are signifi cant in both THA and TKA. Moreover, perioperative anticoagulation prophylaxis, which is recommended in all these patients, is consistently applied in our patients using low-molecular-weight heparins (2, 12) . Other procedures performed in patients of the study group included also surgeries where higher perioperative blood losses are seen (scoliosis, arthroplasty of the shoulder, internal fi xation of the pelvic fracture); however, the number of these procedures was considerably lower in our group compared to procedures associated with minimum perioperative bleeding (cerclage of the olecranon, open reduction and internal fi xation for forearm fractures, proximal femoral nail and dynamic hip screw for hip fractures, cerclage of the patella, non-reamed tibial nail for tibial fractures, open reduction and internal fi xation for ankle fractures).
Ischaemic complications are considered serious for the patient's prognosis as well as for the long-term result of surgery. We did not demonstrate an increased incidence of such complications in our group in patients after THA or TKA.
Numerous studies reported high postoperative blood losses after TKA implantation (6, 13, 14) . As shown by our study, the difference in the incidence of bleeding complications in patients after THA compared to that after TKA was not signifi cant. In our opinion, this is a very important fi nding especially for patients with the history of cardiac disease who require perioperative anticoagulation prophylaxis for both types of arthroplasty implantations (2). Higher perioperative blood losses in THA need not mean a higher incidence of subsequent bleeding complications.
Given the signifi cantly higher incidence of bleeding complications and insignifi cant difference in the incidence of ischaemic complications in patients after THA or TKA compared to patients after other orthopaedic procedures, we can ask whether consistent perioperative anticoagulation prophylaxis in patients with arthroplasty may be the reason for the reduced incidence of ischaemic complications or the cause of increased incidence of bleeding complications (4, 5, 7, 12, 15, 16) . We cannot answer this speculative question based on the results achieved in our study.
Conclusion
The study showed a signifi cantly higher incidence of bleeding complications in patients after THA and TKA compared with other orthopaedic and traumatological surgeries of the musculoskeletal system in patients with a history of cardiac disease. The incidence of ischaemic complications in patients after THA or TKA was insignifi cantly lower than in those after other musculoskeletal surgeries. The difference in the incidence of bleeding and ischaemic complications in patients after THA compared to TKA was not signifi cant.
